Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-390506 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
30,464
Total Value
$980,263.27
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 10, 2026 | Sale | 29,025 | $32.13 | $932,552.93 | 3,614,495 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Sale | 1,439 | $33.16 | $47,710.33 | 3,613,056 | Direct | โ | View Details |